Kangmei Pharma | 600518 - Current Assets

Stock Price
1.75
Daily Change
-0.08 -4.37%
Monthly
-5.91%
Yearly
-7.89%
Q2 Forecast
1.71

Kangmei Pharma reported CNY7.03B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Genomma Lab Internacional MXN 12.84B 17.52M Dec/2025
Hypermarcas BRL 6.05B 238.85M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Jiangsu Hengrui CNY 51.49B 90.83M Dec/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Sh Fosun Pharma CNY 33.82B 1.68B Dec/2025
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Viatris USD 9.79B 162.2M Dec/2025
Wuxi Apptec CNY 61.68B 7.86B Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025
Zz Pientze Pharmaceu CNY 10.7B 1.59B Sep/2025